This site uses cookies to provide you with a more responsive and personalized service. By using this site you agree to our use of cookies. Please read our cookie notice for more information on the cookies we use and how to delete or block them.

Bookmark Email Print page

Life sciences

At the forefront of a changing industry

Life Sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions to address today's most pressing challenges. The Life Sciences and Health Care industry group understands the complexity of these challenges, and works with clients worldwide to drive progress and bring discoveries to life. As technology, government, and research shape the evolution of the life sciences industry, Deloitte's global network can help clients address today's challenges and prepare for the future. To learn more about Deloitte's global industry practice and the services offered to clients, contact the LSHC group.

Transformation beyond reform: A changing life sciences & health care industry Transformation beyond reform: A changing life sciences & health care industry
In conjunction with the Financial Times/Deloitte 2013 Health Care & Life Sciences conference, explore what lies ahead for global life sciences companies as they focus on the practicalities of dealing with the provisions and impacts of U.S. health care reform.
   
Health care reform and life sciences: Threat, opportunity or both? Health care reform and life sciences: Threat, opportunity or both?
New survey shows enhancing innovation, reducing costs, widening market access, and changing sales models are seen as major impacts on the life sciences industry from health care reforms around the world.
   
Opportunities and change in the pharmaceutical industry Opportunities and change in the pharmaceutical industry
Deloitte Mexico event explores the latest developments and importance of the pharma sector in Mexico, and the challenges and opportunities in the areas of regulatory and compliance.
   
2013 Global life sciences sector outlook 2013 Global life sciences sector outlook
New report examines the current state of the global life sciences industry, explores top issues, reviews activity in a number of geographic markets, and suggests considerations for companies as they seek to grow revenue and market share in 2013 and beyond.
   
   
   
 
   
   
   
   
   
   
 

More Learn more

  • Measuring the return from pharmaceutical innovation 2012
    Exploring the pharmaceutical industry's performance.
  • Life Sciences: Accounting and Financial Reporting Update
    Specialized life sciences accounting and reporting considerations.
  • Global HCP transparency study
    Provides insights into countries' current and anticipated regulatory requirements.

Related links

  • Follow us on Twitter
    Get our latest health care Tweets.
  • Life Sciences research
    The latest industry reports.
  • Complimentary subscriptions
    Latest offerings.
  • Deloitte Recap LLC
    Learn more.
  • Meet our people
    Leadership profiles.

Stay connected

  • Contact us
  • Submit RFP
  • Global blog
  • Global podcasts
  • Social media
  • RSS feed
Stay connected:
Get connected
Share your comments

More on Deloitte
Learn about our site


Recently blogged